- Can anthracycline therapy for pediatric malignancies be less cardiotoxic?Joy M Fulbright
Children s Mercy Hospitals and Clinics, Kansas City, MO 64108, USA
Curr Oncol Rep 12:411-9. 2010..We provide a review of these strategies, focusing on studies in pediatric patients when available, and support the idea that anthracycline therapy can be less cardiotoxic in pediatric patients...
- Late effects of childhood leukemia therapyJoy M Fulbright
Division of Pediatric Hematology Oncology, Children s Mercy Hospital, Kansas City, MO 64108, USA
Curr Hematol Malig Rep 6:195-205. 2011..As clinicians have become more aware of the late effects of therapy, treatment regimens have been changed to decrease late effects, but patients still require long-term follow-up for their prevention and treatment...